Impact of add-back FSH on human and mouse prostate following gonadotropin ablation by GnRH antagonist treatment
Author(s) -
Eleftherios E. Deiktakis,
Eleftheria Ieronymaki,
Peter Zarén,
Agnes Hagsund,
Elin Wirestrand,
Johan Malm,
Christos Tsatsanis,
Ilpo Huhtaniemi,
Aleksander Giwercman,
Yvonne Lundberg Giwercman
Publication year - 2022
Publication title -
endocrine connections
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.941
H-Index - 23
ISSN - 2049-3614
DOI - 10.1530/ec-21-0639
Subject(s) - flutamide , endocrinology , medicine , testosterone (patch) , prostate , luteinizing hormone , prostate cancer , follicle stimulating hormone , gonadotropin releasing hormone antagonist , androgen , gonadotropin , hormone , gonadotropin releasing hormone , androgen receptor , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom